Sign Up to like & get
recommendations!
1
Published in 2017 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-17-2343
Abstract: Purpose: Ras-GTPase–activating proteins (RasGAP), notably NF1 and RASA1, mediate negative control of the RAS/MAPK pathway. We evaluated clinical and molecular characteristics of non–small cell lung carcinoma (NSCLC) with RASA1 mutations in comparison with NF1-mutated cases.…
read more here.
Keywords:
rasa1 nf1;
truncating mutations;
rasa1;
cancer ... See more keywords